"There is a clear association between the use of GLPs and increased risks of food retention during upper endoscopy," Mathur ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

Other pharmaceutical companies are also entering the race to develop oral GLP-1 treatments. Eli Lilly is testing an experimental drug called orforglipron which targets the same pathway as semaglutide.

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences. Review: ...

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

One of the most popular GLP-1 receptor agonists is Ozempic, a semaglutide medication that's technically designed to help ...